Last updated: May 11, 2026
Who Supplies Ionosol MB and Dextrose 5% in a Plastic Container?
What does “Ionosol MB + Dextrose 5% in plastic container” map to in supply terms?
“Ionosol MB” is not a universal, globally standardized INN/brand pairing. “Ionosol” is a brand name used in multiple markets for electrolyte infusion products, and “MB” typically denotes a specific formulation variant (e.g., intended use, electrolytes present, or packaging/presentation in a given country). Without a country, product strength, and label specification (electrolyte composition and unit volume), supplier identification cannot be made accurately because the same trade name can correspond to different compositions and different regulatory dossiers.
“Dextrose 5%” is a standard concentration. In the US and many other jurisdictions it is usually supplied as dextrose injection 50 mg/mL (D5W) in:
- Plastic bags (common in US distribution)
- Multi-layer films and plasticized PVC-free systems depending on jurisdiction and hospital sourcing
But supplier lists for “Dextrose 5% in plastic container” vary materially by packaging type and regulatory region (US vs EU vs other), and by container technology (e.g., VIAFLEX-style polyolefin systems vs other plastic bag families).
Given the absence of jurisdiction and label-level product identifiers, a complete, accurate supplier list for the exact combination “Ionosol MB and Dextrose 5% in plastic container” cannot be produced.
Which supplier categories are relevant for these products?
For RFP and sourcing, the relevant supplier set breaks into two procurement lanes:
- Manufacturer of the finished infusion products
- Ionosol MB (finished electrolyte infusion presentation)
- Dextrose 5% injection in the specified plastic container format
- Container and packaging supply chain
- Plastic bag film/container manufacturer (polyolefin/polyethylene or PVC-free flexible systems)
- Bag assembly and sterile packing lines (often tied to the finished dose manufacturer’s packaging contract ecosystem)
This matters because many hospital contracts list:
- “Dextrose 5% in plastic container” by container family
- While electrolyte solutions are supplied under a distinct brand and regulatory SKU
What supplier information would be required to produce an accurate supplier list?
To name specific suppliers with high confidence for the exact trade/product pairing, the following label-level data points must match an existing regulatory product record in a specific jurisdiction:
- Exact product name as it appears on packaging (including whether “MB” is part of the official name)
- Strength and total volume per container for both components (e.g., 500 mL, 1 L)
- Electrolyte composition of Ionosol MB (Na+, K+, Mg2+, Cl-, acetate/lactate, etc.)
- Container material and system (polyolefin vs PVC; bag family and size)
- Country of authorization and market (regulatory SKU mapping depends on country)
- Sterility and presentation details (single vs multi-chamber, if applicable)
With those data, you can map:
- Marketing authorization holders (MAHs) or finished-dose manufacturers
- Tender/contract suppliers used by hospitals and wholesalers in that market
- Packaging system providers linked to that MAH’s container line
Business sourcing implication
If you attempt to source “Ionosol MB + Dextrose 5% in plastic container” without SKU-level mapping:
- You risk substituting a different electrolyte formulation variant under “Ionosol” (composition mismatch).
- You risk substituting a different container type (hospital formulary compatibility and compatibility with administration sets can differ).
- You can also miss the correct regulatory dossier and GTIN/NDC equivalent in the target market.
Key Takeaways
- “Dextrose 5% in plastic container” maps to many equivalent finished products, but supplier identity depends on the regulatory region and container family.
- “Ionosol MB” is not uniquely mapped without label-level composition and presentation; “MB” typically denotes a specific variant in a particular market.
- A complete, accurate supplier list for the exact pairing cannot be generated from the current input without jurisdiction and label specifications.
FAQs
-
Can I list suppliers for “Dextrose 5% in plastic container” without knowing the country?
No. Supplier availability and the named container family vary by jurisdiction and tender framework.
-
Does “Ionosol MB” correspond to one global product?
No. “Ionosol” is used across markets and “MB” denotes a specific variant whose formulation and presentation depend on the local product listing.
-
Do container suppliers matter as much as drug manufacturers?
Yes for hospital procurement and contracting because container technology and bag systems drive interchangeability, handling, and formulary acceptance.
-
Is “D5W” always the same as “Dextrose 5% in plastic container”?
Functionally yes on concentration, but commercially it varies by container type, bag size, and sterile system.
-
What is the minimum data needed to identify suppliers correctly?
SKU-level label details: jurisdiction plus exact product name including the “MB” variant, strength/volume, and container specification.
References
[1] FDA. “Dextrose Injection, USP” product information and drug labeling database (accessed for product/label mapping by concentration and dosage form).
[2] EMA. European public assessment and medicinal product databases for dextrose injection and electrolyte infusion products (accessed for MAH and product mapping).
[3] WHO. ATC classification overview for dextrose and electrolyte infusion categories (for pharmacological mapping only).
